Trademark: 97100521
Status Date
Monday, October 16, 2023
Filing Date
Friday, October 29, 2021
Published for Opposition
Tuesday, July 19, 2022
Abandoned Date
Monday, October 16, 2023
5 Pharmaceutical preparations for the treatment of autoimmune and inflammatory diseases and disorders; Pharmaceutical preparations for the treatment of alopecia areata, vitiligo, inflammatory bowel disease, ulcerative colitis, and Crohn's disease
The mark consists of a set of angled parallel wavy lines with a third wavy line connecting across the parallel lines.
Oct 16, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Oct 16, 2023
Abandonment - No Use Statement Filed
Mar 28, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Mar 28, 2023
Teas Change Of Correspondence Received
Mar 28, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 28, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 28, 2023
Teas Change Of Owner Address Received
Feb 11, 2023
Notice Of Approval Of Extension Request E-Mailed
Feb 9, 2023
Sou Extension 1 Granted
Feb 9, 2023
Sou Extension 1 Filed
Feb 9, 2023
Sou Teas Extension Received
Sep 13, 2022
Noa E-Mailed - Sou Required From Applicant
Jul 19, 2022
Official Gazette Publication Confirmation E-Mailed
Jul 19, 2022
Published For Opposition
Jun 29, 2022
Notification Of Notice Of Publication E-Mailed
Jun 14, 2022
Approved For Pub - Principal Register
Jun 14, 2022
Assigned To Examiner
Nov 13, 2021
Notice Of Design Search Code E-Mailed
Nov 12, 2021
New Application Office Supplied Data Entered
Nov 2, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
